Target intelligence / Profile preview

ANKRD13C divergent transcript (ANKRD13C-DT)

Target
ANKRD13C-DT
Molecular classification
Long non-coding RNA (lncRNA), Other
01

Overview

ANKRD13C divergent transcript (ANKRD13C-DT), also known as HHLA3 and other aliases, is classified as a long non-coding RNA (lncRNA) gene in humans[4][7]. While the gene is annotated and known to exist, there is currently no confirmed protein product, and its function remains uncharacterized[4][10]. The alternative names reflect historical annotations linking it to putative protein products and associations with endogenous retrovirus-related sequences, but there is no established evidence of physiological or pathological roles[4][10]. ANKRD13C-DT is not considered a therapeutic target, receptor, enzyme, transporter, or transcription factor, and there are no known drugs, biomarkers, or documented disease associations directly linked to it[4][10].

Other names
HHLA3Putative uncharacterized protein ANKRD13C-DTHERV-H LTR-associating protein 3HERV-H LTR-associating 3Human endogenous retrovirus-H long terminal repeat-associating 3
02

Biological functions

Unknown
03

Disease associations

Other

Beyond the preview

Go deeper on ANKRD13C divergent transcript (ANKRD13C-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ANKRD13C divergent transcript (ANKRD13C-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call